Skip Nav Destination
Issues
Biochemical Society Focused Meetings
Cofactor processing in galactose oxidase
S.J. Firbank; M. Rogers; R. Hurtado-Guerrero; D.M. Dooley; M.A. Halcrow; S.E.V. Phillips; P.F. Knowles; M.J. McPherson
Biochem Soc Trans (2003) 31 (3): 506–509.
What can structure tell us about in vivo function? The case of aminoglycoside-resistance genes
Biochem Soc Trans (2003) 31 (3): 520–522.
Molecular mechanism for inhibition of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase by rosuvastatin
Biochem Soc Trans (2003) 31 (3): 528–531.
A structural perspective on the enzymes that convert dTDP-d-glucose into dTDP-l-rhamnose
C. Dong; K. Beis; M.-F. Giraud; W. Blankenfeldt; S. Allard; L.L. Major; I.D. Kerr; C. Whitfield; J.H. Naismith
Biochem Soc Trans (2003) 31 (3): 532–536.
Experiences with the shikimate-pathway enzymes as targets for rational drug design
Biochem Soc Trans (2003) 31 (3): 548–552.
A two-faced molecule offers NO explanation: the proximal binding of nitric oxide to haem
Biochem Soc Trans (2003) 31 (3): 553–557.
Structural insights into the evolution of the pantothenate-biosynthesis pathway
C.M.C. Lobley; F. Schmitzberger; M.L. Kilkenny; H. Whitney; H.H. Ottenhof; E. Chakauya; M.E. Webb; L.M. Birch; K.L. Tuck; C. Abell; A.G. Smith; T.L. Blundell
Biochem Soc Trans (2003) 31 (3): 563–571.
United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling
Biochem Soc Trans (2003) 31 (3): 573–578.
Targeting metabolic pathways in microbial pathogens: oxidative stress and anti-folate drug resistance in trypanosomatids
Biochem Soc Trans (2003) 31 (3): 607–610.
Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function
Biochem Soc Trans (2003) 31 (3): 615–619.
Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis
A.W. Munro; K.J. McLean; K.R. Marshall; A.J. Warman; G. Lewis; O. Roitel; M.J. Sutcliffe; C.A. Kemp; S. Modi; N.S. Scrutton; D. Leys
Biochem Soc Trans (2003) 31 (3): 625–630.
Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome
N.J.A. Child; I.A. Yang; M.C.K. Pulletz; K. de Courcy-Golder; A.-L. Andrews; V.J. Pappachan; J.W. Holloway
Biochem Soc Trans (2003) 31 (3): 652–653.
Toll-like receptor 9: modulation of recognition and cytokine induction by novel synthetic CpG DNAs
Biochem Soc Trans (2003) 31 (3): 654–658.
Evolutionary relationships, but functional differences, between the Drosophila and human Toll-like receptor families
Biochem Soc Trans (2003) 31 (3): 659–663.
Independent Meetings
DNA replication in the hyperthermophilic archaeon Sulfolobus solfataricus
Biochem Soc Trans (2003) 31 (3): 674–676.
Immunoglobulin-binding domains: Protein L from Peptostreptococcus magnus
Biochem Soc Trans (2003) 31 (3): 716–718.
Human porphobilinogen deaminase mutations in the investigation of the mechanism of dipyrromethane cofactor assembly and tetrapyrrole formation
Biochem Soc Trans (2003) 31 (3): 731–735.
